应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02359 药明康德
休市中 08-14 16:08:36
197.400
-5.800
-2.85%
最高
201.800
最低
194.700
成交量
662.31万
今开
199.000
昨收
203.200
日振幅
3.49%
总市值
5,851亿
流通市值
967.26亿
总股本
29.64亿
成交额
13.09亿
换手率
1.35%
流通股本
4.90亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据
美股速递 · 08-14 17:51
摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据
创新药概念集体回调 康方生物（09926）跌6.85%、维亚生物（01873）跌6.33%
金吾财讯 · 08-14 13:51
创新药概念集体回调 康方生物（09926）跌6.85%、维亚生物（01873）跌6.33%
异动解读｜药明康德盘中下跌3.15%，报196.8港元
行情直击 · 08-14 11:01
异动解读｜药明康德盘中下跌3.15%，报196.8港元
CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳
新浪基金 · 08-13 11:25
CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳
美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价
智通财经 · 08-13 10:20
美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价
大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价
格隆汇 · 08-13 10:20
大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价
智通AH统计|8月12日
智通财经 · 08-12
智通AH统计|8月12日
港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单
智通财经 · 08-11
港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单
创新药概念继续走强 金斯瑞生物科技（01548）涨6.87% 机构指中国创新药全球地位持续提升
金吾财讯 · 08-11
创新药概念继续走强 金斯瑞生物科技（01548）涨6.87% 机构指中国创新药全球地位持续提升
异动解读｜药明康德盘中上涨3.03%，美法院初步禁令解除1260H不明朗因素持续发酵
行情直击 · 08-11
异动解读｜药明康德盘中上涨3.03%，美法院初步禁令解除1260H不明朗因素持续发酵
大和：上调药明康德(02359.HK)目标价至230港元 重申行业首选
智通财经 · 08-11
大和：上调药明康德(02359.HK)目标价至230港元 重申行业首选
药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
金吾财讯 · 08-11
药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
药明康德：公司将于2026年9月29日召开2026年第一次临时股东会
证券日报网 · 08-10
药明康德：公司将于2026年9月29日召开2026年第一次临时股东会
FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元
智通财经 · 08-10
FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元
药明康德（02359）发布海外监管公告 将于2026年首度临时股东大会审议A股员工持股计划及修订章程
公告速递 · 08-10
药明康德（02359）发布海外监管公告 将于2026年首度临时股东大会审议A股员工持股计划及修订章程
大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素
格隆汇 · 08-10
大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素
中泰国际：维持药明康德(02359.HK)“买入”评级 目标价216港元
智通财经 · 08-10
中泰国际：维持药明康德(02359.HK)“买入”评级 目标价216港元
大摩：药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素
智通财经 · 08-10
大摩：药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素
时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！
新浪基金 · 08-10
时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！
AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令
格隆汇 · 08-10
AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令
加载更多
公司概况
公司名称：
药明康德
所属市场：
SEHK
上市日期：
--
主营业务：
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格：
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":197.4,"timestamp":1786694916003,"preClose":203.2,"halted":0,"volume":6623116,"delay":0,"changeRate":-0.02854330708661409,"floatShares":490000000,"shares":2964000000,"eps":7.690547102444385,"marketStatus":"休市中","change":-5.8,"latestTime":"08-14 16:08:36","open":199,"high":201.8,"low":194.7,"amount":1309016492,"amplitude":0.034941,"askPrice":197.4,"askSize":6700,"bidPrice":197.3,"bidSize":53500,"shortable":3,"etf":0,"ttmEps":8.573340466794837,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":7,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":203.2,"dividendRate":0.009772,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.6675718391238791,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":159.24,"timestamp":1786690800000,"preClose":162.33,"halted":0,"volume":54590100,"delay":0,"premium":"+6.55"},"impliedVol":0.4425,"impliedVolPercentile":0.3786},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"1125476643","title":"摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1125476643","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125476643?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:51","pubTimestamp":1786701088,"startTime":"0","endTime":"0","summary":"摩根大通在药明康德H股的空头头寸比例出现显著增长。根据香港交易所最新披露的数据，截至8月11日，该行在药明康德H股上的空头头寸占总股本的比例已从之前的2.66%攀升至3.19%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU1979443071.USD","LU1997245094.SGD","LU1997245177.USD","IE00B543WZ88.USD","LU1303224171.USD","LU2045819591.USD","LU0320764599.SGD","LU0348767384.USD","LU1770034418.SGD","LU0708995583.HKD","02359","BK1583","LU1934453819.USD","LU1808992512.USD","LU1046422090.SGD","603259","LU0700851271.USD","LU2488822045.USD","LU2242644610.SGD","LU0456842615.SGD","IE00BPRC5H50.USD","LU2495084118.USD","BK1141","LU0469268626.HKD","LU2125910500.SGD","LU0572944931.SGD","LU0327786744.USD","LU0611395673.USD","LU1251922891.USD","LU0052750758.USD","LU0348766576.USD","LU1997244956.HKD","IE00B5MMRT66.SGD","BK1576","BK0216","LU1719994722.HKD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659299118","title":"创新药概念集体回调 康方生物（09926）跌6.85%、维亚生物（01873）跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659299118","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659299118?lang=zh_cn&edition=full","pubTime":"2026-08-14 13:51","pubTimestamp":1786686711,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念集体回调，康方生物 跌6.85%，维亚生物跌6.33%，思路迪医药股份跌6.15%，恒瑞医药跌5.10%，晶泰控股跌4.88%，凯莱英跌4.67%，亚盛医药跌4.04%，药明康德跌3.94%，百济神州跌3.92%。西南证券表示，CXO+创新药放量领涨，8-9月有望迎来业绩+临床数据共振。从产业链的角度，CXO板块投融资改善明显，26H1中国/全球医疗健康投融资分别676.47亿元/2416.43亿元，ADC、多肽、细胞基因治疗等新药物形式赛道持续火热，头部CXO公司海外订单复苏明显。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1794554557.SGD","BK1588","LU0348766576.USD","LU1251922891.USD","LU2045819591.USD","BK1576","LU0634319403.HKD","06978","LU0359202008.SGD","LU0708995583.HKD","LU0307460666.USD","LU0561508036.HKD","LU2242644610.SGD","LU2399975544.HKD","KURE","LNGR","LU0828237510.HKD","06821","IE00B543WZ88.USD","159992","LU0228659784.USD","09926","LU2778985437.USD","LU0348784397.USD","02359","06855","LU1770034418.SGD","06160","LU1961090484.USD","IE00B5MMRT66.SGD","01244","LU2476274720.SGD","MEDX","BK1574","02228","LU2476274308.USD","01276","BK1617","LU0572944931.SGD","01873","LU0327786744.USD","LU0348827113.USD","LU0052750758.USD","LU0359201612.USD","LU1720050803.USD","LU0348783233.USD","LU1719994722.HKD","LU0588546209.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127051465","title":"异动解读｜药明康德盘中下跌3.15%，报196.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127051465","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127051465?lang=zh_cn&edition=full","pubTime":"2026-08-14 11:01","pubTimestamp":1786676510,"startTime":"0","endTime":"0","summary":"8月14日，药明康德盘中下跌3.15%，报196.8港元/股，成交额4.99亿港元。药明康德所在的生命科学工具和服务行业中，板块整体走弱，个股中，药明生物跌0.74%，金斯瑞生物科技跌2.85%，英矽智能跌3.58%，晶泰控股跌3.36%，药明合联跌1.34%。公司是一家主要从事新药研发和生产服务业务的公司，主要通过化学业务、测试业务、生物学业务、高端治疗CTDMO业务、国内新药研发服务及其他业务分部开展业务，为全球药企提供从药物发现到商业化生产的一站式外包服务。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187744","title":"CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187744","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659187744?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:25","pubTimestamp":1786591500,"startTime":"0","endTime":"0","summary":"8月13日，AH医疗板块迅速反弹。CXO强者恒强，药明康德AH股双双涨逾1%，康龙化成AH股齐升逾4%，A股皓元医药涨超7%。场内高CXO含量ETF同步走走强，CXO含量超50%的港股通医疗ETF华宝涨逾1%。全市场规模最大医疗ETF华宝CXO含量超30%，盘中涨超2%冲击五连阳，成交超4.5亿元。紧跟医疗反攻行情，关注两大“利器”：港股通医疗ETF华宝：最新CXO含量达51.88%，其中药明系权重占比超38%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-13/doc-ininctaw3414344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","BK1583","LU2495084118.USD","LU0052750758.USD","LU1997244956.HKD","IE00B5MMRT66.SGD","LU0320764599.SGD","LU1770034418.SGD","BK1576","LU1997245094.SGD","WX","LU0348767384.USD","688131","BK0216","LU1719994722.HKD","LU0700851271.USD","512170","LU0708995583.HKD","BK1141","603259","LU2045819591.USD","LU1979443071.USD","LU0456842615.SGD","LU2242644610.SGD","LU1303224171.USD","LU0611395673.USD","LU2328871848.SGD","LU1046422090.SGD","LU1934453819.USD","LU2125910500.SGD","159828","CXO","LU1808992512.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU1969619763.USD","LU0348766576.USD","LU1251922891.USD","LU1997245177.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182702","title":"美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182702","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659182702?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:20","pubTimestamp":1786587659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","SMCO","BMED","APXH","161027","MEDI","FHLC","PSCH","SURI","XBIX","WX","CXO","PSIL","IBRN","BBC","IDNA","LFSC","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659438182","title":"大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659438182","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659438182?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:20","pubTimestamp":1786587637,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02359","LU1969619763.USD","IE00B543WZ88.USD","LU1303224171.USD","LU0320764599.SGD","LU1719994722.HKD","BK1141","603259","LU0611395673.USD","LU1251922891.USD","BK0216","LU1934453819.USD","LU0456842615.SGD","LU0708995583.HKD","LU2495084118.USD","BK1576","LU1997245177.USD","LU1997245094.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1583","LU0052750758.USD","LU0348767384.USD","LU2328871848.SGD","LU0700851271.USD","LU1808992512.USD","LU1046422090.SGD","LU2045819591.USD","LU0348766576.USD","LU2125910500.SGD","LU1979443071.USD","LU1997244956.HKD","LU2242644610.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658171927","title":"智通AH统计|8月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2658171927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658171927?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:15","pubTimestamp":1786522505,"startTime":"0","endTime":"0","summary":"东北电气0.2412.251020.33%74.06%浙江世宝3.91515.13362.84%16.88%弘业期货2.3007.82307.39%9.97%中石化油服0.6552.22306.11%-8.99%复旦张江2.5057.93279.24%5.83%安德利果汁21.16066.61277.08%-25.38%南京熊猫电子股份3.45010.25255.94%20.79%晨鸣纸业0.6501.93255.38%-8.27%凯盛新能2.4207.15253.72%7.62%京城机电股份3.0758.73240.16%15.98%. 宁德时代654.000393.93-27.85%-0.33%药明康德198.900158.38-4.62%-0.24%兆易创新515.000413.17-3.90%-4.40%招商银行48.02038.79-3.25%0.13%中际旭创1109.000921-0.53%-6.08%潍柴动力36.40031.313.02%3.34%美的集团96.10084.485.30%-1.43%立讯精密63.65057.357.92%-12.58%紫金矿业35.92033.5811.97%-2.70%中国平安55.55052.4513.09%0.92%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03678","159982","02359","LU0856984785.SGD","06693","03968","03200","03143","PNGAY","00553","HPAD.SI","03986","LU0128522157.USD","EWH","06613","03993","00042","00187","01989","06067","00300","03750","02691","IE0031814852.USD","02475","82318","00763","02768","01349","399300","03145","03308","02899","06745","01033","01812","01057","01688","01108","LU0051755006.USD","06655","PAImain","601318","LU0210526637.USD","02218","02318","02338","00991","02865"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969972","title":"港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969972","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969972?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:47","pubTimestamp":1786420064,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052750758.USD","LU2125910500.SGD","BK1576","LU2242644610.SGD","LU0320764599.SGD","02359","LU0348766576.USD","LU0708995583.HKD","LU0348767384.USD","LU1046422090.SGD","BK1141","LU2045819591.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658369969","title":"创新药概念继续走强 金斯瑞生物科技（01548）涨6.87% 机构指中国创新药全球地位持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658369969?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强，截至发稿，金斯瑞生物科技 涨6.87%，再鼎医药涨5.51%，同源康医药-B涨4.81%，晶泰控股涨3.94%，药明合联涨3.92%，翰森制药涨3.76%，亚盛医药涨3.63%，百济神州涨3.38%，药明康德涨3.03%，诺诚健华涨2.83%，石药集团涨2.78%。国元国际证券亦表示，出海交易量价齐升，中国创新药全球地位持续提升。中国创新药出海持续超预期，上半年997亿美元的交易总额和全球TOP10中独占8席的成绩，充分验证了中国创新药资产的全球竞争力。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YR35.GBP","KURE","09969","LU1303224171.USD","BK1583","LU1993786604.SGD","LU1226287792.SGD","LU2328871848.SGD","03692","BK1161","IE00B5MMRT66.SGD","MEDX","IE00BZ08YS42.EUR","BK1617","02268","02359","06855","LU0072913022.USD","LU1226287875.USD","LU1951186391.HKD","LNGR","02228","LU2039709279.SGD","LU1813983027.USD","BK1576","LU2125910500.SGD","159992","LU0315179316.USD","BK1500","LU0880133367.SGD","BK1588","06978","LU1226288170.HKD","LU1152091168.USD","IE00BZ08YT58.USD","09688","HK0000320223.HKD","IE00B031HY20.USD","01548","06160","HK0000306685.HKD","IBBQ","LU2488822045.USD","LU0326950275.SGD","02410","01093","LU2242644610.SGD","IE00B543WZ88.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196700801","title":"异动解读｜药明康德盘中上涨3.03%，美法院初步禁令解除1260H不明朗因素持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1196700801","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196700801?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:06","pubTimestamp":1786414011,"startTime":"0","endTime":"0","summary":"8月11日，药明康德盘中上涨3.03%，报204.0港元，成交额5.28亿港元，股价延续近期强势续创历史新高。消息面上，公司此前公告称美国哥伦比亚特区联邦地区法院于8月7日批准其初步禁令动议，禁止美国国防部在司法程序期间执行1260H认定及基于该认定的任何措施。摩根士丹利指出该禁令解除了1260H清单的不明朗因素，中泰国际维持\"买入\"评级，目标价216港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658896570","title":"大和：上调药明康德(02359.HK)目标价至230港元 重申行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2658896570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658896570?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:04","pubTimestamp":1786413860,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1141","LU0708995583.HKD","LU0348766576.USD","LU1046422090.SGD","LU0052750758.USD","LU2242644610.SGD","BK1576","LU2125910500.SGD","LU0320764599.SGD","LU2045819591.USD","LU0348767384.USD","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657219","title":"药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657219","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658657219?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:00","pubTimestamp":1786413650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德（02359）早盘逆市走高，截至发稿，报202港元，涨2.02%，成交额3.7亿港元。大和研报指，美国哥伦比亚特区联邦地区法院颁发初步禁制令，禁止美国国防部将药明康德列入1260H名单，使公司在诉讼期间免受被错误列入1260H名单所带来的不利后果，将目标市盈率由20倍上调至21.5倍，目标价由215港元升至230港元。该行相信，这项初步禁制令是药明康德从1260H名单除名程序及时的第一步，亦代表公司在法律程序中取得初步胜利，维持“买入”评级。重申行业首选。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987890","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","LU1046422090.SGD","IE00B5MMRT66.SGD","LU0348767384.USD","LU1808992512.USD","LU1934453819.USD","LU0052750758.USD","LU2125910500.SGD","LU2488822045.USD","LU1770034418.SGD","LU2495084118.USD","LU1997245094.SGD","LU0708995583.HKD","LU1303224171.USD","LU1969619763.USD","LU0611395673.USD","LU2045819591.USD","LU2328871848.SGD","LU1719994722.HKD","LU0456842615.SGD","BK1583","BK1141","LU1997244956.HKD","603259","LU0348766576.USD","LU1251922891.USD","IE00BPRC5H50.USD","BK1576","LU1979443071.USD","LU1997245177.USD","LU0320764599.SGD","IE00B543WZ88.USD","LU2242644610.SGD","02359","LU0700851271.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939798","title":"药明康德：公司将于2026年9月29日召开2026年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939798","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939798?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:34","pubTimestamp":1786365240,"startTime":"0","endTime":"0","summary":"证券日报网讯 8月10日，药明康德发布公告称，公司将于2026年9月29日召开2026年第一次临时股东会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1576","LU0052750758.USD","LU1303224171.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU1046422090.SGD","LU2495084118.USD","LU0700851271.USD","LU2242644610.SGD","LU1808992512.USD","LU0708995583.HKD","BK1141","603259","LU2488822045.USD","LU0320764599.SGD","LU1719994722.HKD","LU1997245094.SGD","BK0216","LU0348767384.USD","LU2045819591.USD","LU2125910500.SGD","LU1934453819.USD","IE00BPRC5H50.USD","LU1251922891.USD","LU0456842615.SGD","LU1997244956.HKD","LU1969619763.USD","LU0611395673.USD","LU1770034418.SGD","LU2328871848.SGD","BK1583","02359","LU1979443071.USD","IE00B543WZ88.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938739","title":"FMR LLC增持药明康德(02359.HK)约119.31万股 每股作价约180.74港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658938739?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:02","pubTimestamp":1786359720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2045819591.USD","02359","LU0320764599.SGD","BK1576","LU2242644610.SGD","LU1046422090.SGD","LU0052750758.USD","LU0348767384.USD","BK1141","LU0348766576.USD","LU0708995583.HKD","LU2125910500.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173139507","title":"药明康德（02359）发布海外监管公告 将于2026年首度临时股东大会审议A股员工持股计划及修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=1173139507","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173139507?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:20","pubTimestamp":1786357238,"startTime":"0","endTime":"0","summary":"2026年8月10日，药明康德在香港联交所披露海外监管公告，公布公司已于上海证券交易所网站发布《无锡药明康德新药开发股份有限公司2026年第一次临时股东会会议材料》。根据公告，公司将召开2026年第一次临时股东大会，会议将审议四项非累积投票议案，核心议题包括推动A股员工持股计划和修订公司章程以配合香港无纸化证券市场制度。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985600","title":"大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985600","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985600?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:28","pubTimestamp":1786346889,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0320764599.SGD","LU1046422090.SGD","BK0216","LU2328871848.SGD","LU0348766576.USD","LU1934453819.USD","LU1719994722.HKD","LU2045819591.USD","LU0348767384.USD","IE00B543WZ88.USD","LU0611395673.USD","LU1303224171.USD","LU1997244956.HKD","LU1969619763.USD","LU1251922891.USD","LU2125910500.SGD","LU1770034418.SGD","LU1997245177.USD","LU2495084118.USD","LU0700851271.USD","LU0052750758.USD","LU0708995583.HKD","IE00BPRC5H50.USD","BK1583","LU0456842615.SGD","BK1141","LU2488822045.USD","02359","603259","BK1576","IE00B5MMRT66.SGD","LU1808992512.USD","LU1979443071.USD","LU1997245094.SGD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985992","title":"中泰国际：维持药明康德(02359.HK)“买入”评级 目标价216港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985992?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:04","pubTimestamp":1786345467,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052750758.USD","BK1583","LU0708995583.HKD","02359","LU0348767384.USD","BK1576","LU1046422090.SGD","LU2045819591.USD","LU2125910500.SGD","BK1141","LU2242644610.SGD","LU0320764599.SGD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985310","title":"大摩：药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985310?lang=zh_cn&edition=full","pubTime":"2026-08-10 14:47","pubTimestamp":1786344457,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02359","LU0708995583.HKD","LU2125910500.SGD","LU0348766576.USD","LU0348767384.USD","LU2242644610.SGD","BK1576","BK1141","LU1046422090.SGD","BK1583","LU2045819591.USD","LU0052750758.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658043626","title":"时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！","url":"https://stock-news.laohu8.com/highlight/detail?id=2658043626","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658043626?lang=zh_cn&edition=full","pubTime":"2026-08-10 11:17","pubTimestamp":1786331820,"startTime":"0","endTime":"0","summary":"8月10日，A股医疗板块继续向上！CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！全市场规模最大医疗ETF华宝继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！数据显示，医疗ETF华宝标的指数覆盖8只CXO龙头股，最新权重合计32.82%，其中药明康德占比13.42%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159828","603259","BK1574","LU2488822045.USD","BK1161","BK1583","LU1808992512.USD","LU0052750758.USD","LU1046422090.SGD","LU1997244956.HKD","LU1934453819.USD","LU0708995583.HKD","LU2495084118.USD","LU1770034418.SGD","LU0320764599.SGD","LU1997245177.USD","LU2125910500.SGD","LU0456842615.SGD","IE00B543WZ88.USD","LU2328871848.SGD","BK1576","LU1969619763.USD","IE00BPRC5H50.USD","LU0700851271.USD","512170","BK0216","BK1515","399300","159938","LU1303224171.USD","LU0611395673.USD","LU1979443071.USD","BK1141","02359","IE00B5MMRT66.SGD","159982","IPOS","LU0348766576.USD","LU1997245094.SGD","LU2242644610.SGD","09939","LU0348767384.USD","LU1719994722.HKD","LU1251922891.USD","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658601687","title":"AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令","url":"https://stock-news.laohu8.com/highlight/detail?id=2658601687","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658601687?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:37","pubTimestamp":1786329454,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BPRC5H50.USD","LU1770034418.SGD","LU1251922891.USD","LU1808992512.USD","LU1997245094.SGD","LU0708995583.HKD","LU1969619763.USD","LU1997245177.USD","BK0216","LU1979443071.USD","LU2045819591.USD","LU0052750758.USD","LU1303224171.USD","LU1719994722.HKD","LU2242644610.SGD","LU2488822045.USD","LU1934453819.USD","LU0348766576.USD","BK1583","LU0700851271.USD","LU0456842615.SGD","02359","LU2125910500.SGD","BK1576","LU1997244956.HKD","BK1141","LU0320764599.SGD","399300","LU0611395673.USD","603259","LU0348767384.USD","LU2495084118.USD","LU2328871848.SGD","159982","IE00B5MMRT66.SGD","LU1046422090.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":0.1956},{"period":"3month","weight":0.5434},{"period":"6month","weight":0.6103},{"period":"1year","weight":0.8703},{"period":"ytd","weight":1.0264}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002975},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010736},{"month":4,"riseRate":0.5,"avgChangeRate":0.006503},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.08954},{"month":7,"riseRate":0.75,"avgChangeRate":0.092414},{"month":8,"riseRate":0.625,"avgChangeRate":0.065561},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002332},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.00294},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038239}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}